Private credit providers and investors in the second quarter searched for clues about when M&A activity would pick up, and defaults would accelerate. Neither question received a firm answer.
Among credit-specific events, healthcare technology concern Cotiviti remained a sore point, as negotiations between Veritas Capital and Carlyle Group over a purchase of a stake in the company ended. A deal would have valued the business at $15 billion, including debt. Carlyle returned to the negotiating table with a lower offer price, citing a change in market conditions, but then decided not to move forward with the transaction. Negotiations ended on April 11, and Veritas began to notify limited partners of the development, according to press reports.
Cotiviti was in discussions with private credit providers regarding a $5.5 billion unitranche loan to support the transaction. That would have been the largest-ever financing of this type. Notably, market participants are still using the transaction as a comp. Some say that if the deal were to come to the table again, it would garner even more favorable terms than when it was actually in the market, in March and April. More than 10 lenders were said to be participating at that time. Interest was strong, market sources said.
The deal was initially guided at Sofr+650-675, with an OID of 97-97.5, but tighter pricing levels had also been circulating. Apollo and HPS Investment were initially talked as participants. Initially, Goldman Sachs and JP Morgan had been open to a syndicated loan solution for the borrower.
That level of pricing that Cotiviti might have received was in line with the overall market. Generally speaking, pricing in the second quarter was cuffed at Sofr+600-675, with an OID of 97-98, for a high-quality issuer, according to sources.
Private credit trends
In terms of structure, another second-quarter trend was the contraction of delayed-draw term loans (DDTLs). Previously, borrowers could place a DDTL roughly equal in size to a funded loan. Now, they are a fraction of a loan’s funded portion, with one estimate the amount at 10–20% of the size of the funded loan, with ticking fees, as lenders are requiring borrowers to pay for exactly what they get, sources say.
Despite Cotiviti, deals still crossed the finish line in the second quarter, even if activity was less brisk than credit investors would have liked. LCD data for the second quarter showed that, based on issuer count, private credit remained the financing of choice of private equity sponsors for leveraged buyouts.
Private credit outpaced syndicated loans for non-LBOs as well, LCD data shows.
Among transactions, add-on acquisitions were a notable pocket of activity. Private equity sponsors can still find “decent” value among small tack-on purchases for existing portfolio companies, even in the new reality of higher interest rates, sources said. LCD News reported on 25 such transactions in the second quarter, up from 14 in the first quarter. Other relative hot spots in the second quarter included mezzanine financing and middle market CLO activity.
On the flip side, turmoil at US regional banks left market participants fearing the fallout on lending, and on the economy generally. But by quarter-end those worries seemed largely in the rearview mirror.
Long-time broadly syndicated loan issuer Melissa & Doug in early April opted for a direct lending solution to extend an existing term loan. Two weeks before that, the company, a toymaker, brought to the BSL market a transaction to push out the maturity of its $260 million first-lien term loan by two years, to June 2026. The deal highlighted a trend that private credit providers have often cited: borrowers, faced with dislocation and increased uncertainty in the syndicated markets, will opt for the relative immediacy and certainty that direct lenders say they provide.
Despite complaints about a lack of deals, transactions did close. LCD estimates that the volume of M&A financed via directly originated loans totaled $47 billion, a number that exceeded both syndicated loans and high-yield bonds. The volume figure is partly based on estimates that take into account the average size.
But in light of all the fundraising in recent years, it just wasn’t enough for investors in private credit loans.
One leading dealmaker, private equity firm Thoma Bravo, addressed the slowdown in activity that has gripped the market for much of 2023, admitting it was frustrated with the current pace of transactions.
“The entire industry seems paralyzed right now,” said firm founder Orlando Bravo, speaking in a Bloomberg TV interview from the SuperReturn International conference in Berlin on June 8. Bravo provided a ray of hope for the second half of 2023, saying he hoped to close more deals in enterprise software this year, which he considered the firm’s core business.
Thoma Bravo will likely have capital to put to work, too. It looks set to seal an exit of Adenza, the trading and risk management platform formed through the merger of Calypso Technology and AxiomSL. Nasdaq, rated BBB/Baa3, disclosed that on June 10 it entered into a commitment letter with Goldman Sachs and JP Morgan providing an up to $5.7 billion senior bridge term loan in connection with the company’s planned $10.5 billion acquisition of Adenza from Thoma Bravo, which is expected to close in six to nine months.
Nasdaq has a $1.25 billion revolver due December 2027, with no amounts outstanding as of March 31. The company has about $4.7 billion outstanding under senior unsecured notes, with maturities ranging from 2026-2052. As of June 16, Nasdaq had amended the credit facility that will allow the borrower to increase leverage to facilitate the acquisition. Bank of America is administrative agent.
At least private equity sponsors had more options for financing in the second quarter of 2023, which featured a continued reopening of the syndicated bank loan market. Private-equity-backed borrowers raised $65.4 billion in the syndicated loan market in the year to June 20, but more than half of this amount supported refinancings. In addition, investor appetite for the riskiest borrowers — those falling into the B-minus ratings bucket — remains limited. Only 34% of 1H23 syndicated loan volume to PE-backed borrowers came from this ratings category, the lowest reading in seven years, down from 64% in 2022.
Refinancing activity is helping volume numbers for the first half of 2023 across both high-yield bonds and leveraged loans.
The leveraged finance pendulum is expected to move slightly further in the direction of the syndicated loan market in the second half of 2023, and away from private credit. This would come as no surprise, as since 2Q22 private credit likely had perhaps 100% of the market share of large-cap buyout financings. But those days are gone, at least for now. Large LBOs are taking a breather. Investors continue to see opportunities in the middle market and lower middle market, sources say. This could be why the volume of deals financed by a single lender has grown, relative to deals financed by three or more lenders, according to LCD data.
To that end, the slowdown in dealmaking was a key topic for attendees of the 2023 Leveraged Finance Fights Melanoma gala at the Museum of Modern Art on June 14. But talk of the new-issue market did not deter the jovial mood. It just shifted expectations for a bounce-back of activity to the second half of 2023, when banks are likely to be formidable competitors to the private credit providers that have dominated the market recently, sources said.
Top-of-mind for attendees at the melanoma research fundraiser was the potential in $5 billion in financing backing a deal for Subway, the sandwich shop. The financing will also likely include bonds and loans. The restaurant chain LBO, which could be a $10 billion deal, has credit investors’ mouths watering.
Dechert LLP Partner Jay Alicandri called what’s happening a “deal drought,” and offered an explanation. “Sponsor buyouts have largely cooled off this year,” said Alicandri, speaking at a press briefing on private credit in Midtown Manhattan on June 14. “People are trying to sell their companies for yesterday’s prices. People are trying to buy companies at where they think they should be priced today.” Alicandri is one of the leaders of the firm’s permanent capital & private credit team. The firm held a roundtable discussion that covered private credit and alternative asset diversification topics, including financing strategies, capital raising, and innovative structures.
The law firm’s team also addressed the other looming question of the second quarter: the magnitude and timing of the expected wave of defaults. That hasn’t happened yet, though defaults are ticking higher.
In response to a question on stressed private credit loans, Alicandri said, “Do we have more now in our portfolio than a year ago? Absolutely. Is it 2008? No.”
Alicandri added that people were “generally confident” in their loan portfolios.
Echoing this sentiment, Boston-based Dechert partner Tom Friedmann said data on loan defaults and non-accrual loans in BDCs had so far not reflected major issues. “Everyone’s waiting to see that default rate creep up. It hasn’t happened yet,” said Friedmann, who is co-head of Dechert’s permanent capital & private credit team.
Coverage concerns
But in sign that more distress is around the corner, Lincoln International said private companies were experiencing “notable and worrying” declines in fixed-charge coverage ratios (FCCRs), showing that many levered companies are struggling to pay interest as borrowing costs rise. Pro forma for a 5.5% base rate, nearly half of companies — 45% — would have fixed-charge coverage ratios below 1.0x as of the first quarter of 2023. Many of these borrowers have seen their all-in interest expenses double since early 2022 for the same amount of debt, according to Lincoln.
“Accordingly, lenders are now underwriting to a forward-looking FCCR that incorporates expectations for interest rates, which is constraining the amount of debt a company can support and, by extension, depressing leverage multiples,” the June 2023 report stated.
Learn about our editorial standards.